23 September 2021

Biologics Gout

Have JAK inhibitors failed to meet their promise?

23 September 2021

Comment DMARDS Medicare

Medicare: how it started, how it’s going

9 September 2021

Biologics PBS

Regulatory review – July 2021 PBAC recommendations

2 September 2021

Analgesics Conditions Scleroderma

New hub for patients living with psoriatic arthritis

2 September 2021

COVID-19 NSAIDS Podiatry

On Spandex, coffee and other covid measures

26 August 2021

COVID-19 DMARDS Technology

Most specialists soon to lose remote prescribing capabilities

19 August 2021

Analgesics

Diagnosing familial Mediterranean fever

19 August 2021

Medications Public Health

Australia’s health system takes bronze

19 August 2021

Biologics COVID-19

Don’t wanna get caught short

12 August 2021

Analgesics COVID-19

Growing clamour for booster shots in immunocompromised patients

12 August 2021

Biologics COVID-19

New ACR guidelines for covid vax in rheuma patients

5 August 2021

Analgesics

Gold rush! Rheumatology meets the Olympics

5 August 2021

Biologics Reactive Arthritis

Anifrolumab breaks lupus green-light drought in the US

29 July 2021

Biologics Conditions Mental Health

Loneliness predicts use of risky medications

29 July 2021

Biologics

ATAGI recommends Shingrix for immunocompromised patients

29 July 2021

Biologics COVID-19 TGA

Covid-19 impacts on people with rheumatic disease: survey